
FUL
H. B. Fuller Company
$63.68
$0.00(0.00%)
71
Overall
100
Value
63
Tech
52
Quality
Market Cap
$3.14B
Volume
635.07K
52W Range
$47.56 - $68.63
Target Price
$70.14
Latest News for FUL
Fulcrum Extends Pociredir Program With Long-Term Sickle Cell Study
TipRanks Clinical-Trials-Auto-Generated Newsdesk•21 days ago•Mar 20, 2026
Fulcrum Therapeutics ($FULC) announced an update on their ongoing clinical study. Fulcrum Therapeutics is launching an open-label extension study c......
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Fulcrum Therapeutics (FULC)
Howard Kim•21 days ago•Mar 20, 2026
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Taysha Gene Therapies (TSHA) and Fulcrum Therapeutic......
News data is sourced from MarketXLS API and updated regularly.
Showing 2 of 2 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FUL | $63.68 | 0% | 635.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |